UMIN ID: UMIN000044727
Registered date:02/07/2021
Verification study on the effect of food material intake on abdominal visceral fat-Randomized, double-blind, placebo-controlled parallel group study-
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Not applicable |
Date of first enrollment | 2021/08/17 |
Target sample size | 90 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Intake of test food for 12 weeks Intake of placebo food for 12 weeks |
Outcome(s)
Primary Outcome | Visceral fat area |
---|---|
Secondary Outcome | Body weight,BMI,Waist circumference,hip circumference, W/H ratio,Subcutaneous fat area,total fat area,total cholesterol,LDL- cholesterol,HDL- cholesterol,triglyceride,glucose,HbA1c |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 65years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1)Subjects who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs 2)Subjects who dyslipidemia, high blood pressure, or diabetes 3)Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study 4)Subjects who regularly use health foods and supplements affecting the study 5)Possible pregnancy, pregnancy and lactation 6)Heavy drinkers 7)Subjects who feel bad mood by blood collect 8)Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period 9)Those who have been diagnosed with chronic constipation 10)Shift worker 11)Subjects who plan business trip or trip for 10 days or more a month 12)Subjects who have allergy related to the test foods 13)Subjects already participating in other clinical trials 14)Subjects who are ineligible due to physician's judgment |
Related Information
Primary Sponsor | Maruzen Pharmaceuticals Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Maruzen Pharmaceuticals Co., Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Tomoya Yuhki |
Address | 452-1 Toiso,Eniwa,Hokkaido,Japan Japan 061-1405 |
Telephone | 0123-34-0412 |
t-yuhki@ndrcenter.co.jp | |
Affiliation | New drug research center, Inc. Clinical Research Dept. |
scientific contact | |
Name | Ikuo Fukuhara |
Address | 3-1-15 Shimamatsuhigashi-machi, Eniwa, Hokkaido, Japan Japan |
Telephone | 0123-36-8029 |
i-feniwa@gray.plala.or.jp | |
Affiliation | Fukuhara Clinic Hospital director |